Kiley S - Search Results

1

Post-transplantation lymphoproliferative disorder in the Epstein-Barr virus-naïve lung transplant recipient.

Aris RM, Maia DM, Neuringer IP, Gott K, Kiley S, Gertis K, Handy J. Aris RM, et al. Among authors: kiley s. Am J Respir Crit Care Med. 1996 Dec;154(6 Pt 1):1712-7. doi: 10.1164/ajrccm.154.6.8970360. Am J Respir Crit Care Med. 1996. PMID: 8970360

2

Phorbol ester treatment of U937 cells with altered protein kinase C content and distribution induces cell death rather than differentiation.

de Vente J, Kiley S, Garris T, Bryant W, Hooker J, Posekany K, Parker P, Cook P, Fletcher D, Ways DK. de Vente J, et al. Among authors: kiley s. Cell Growth Differ. 1995 Apr;6(4):371-82. Cell Growth Differ. 1995. PMID: 7794805

3

Cloning and characterization of phorbol ester differentiation-resistant U937 cell variants.

Kiley SC, Adams PD, Parker PJ. Kiley SC, et al. Cell Growth Differ. 1997 Feb;8(2):221-30. Cell Growth Differ. 1997. PMID: 9040944

4

Defective microtubule reorganization in phorbol ester-resistant U937 variants: reconstitution of the normal cell phenotype with nocodazole treatment.

Kiley SC, Parker PJ. Kiley SC, et al. Cell Growth Differ. 1997 Feb;8(2):231-42. Cell Growth Differ. 1997. PMID: 9040945

5

Tetradecanoyl phorbol acetate-induced microtubule reorganization is required for sustained mitogen-activated protein kinase activation and morphological differentiation of U937 cells.

Whelan RD, Kiley SC, Parker PJ. Whelan RD, et al. Among authors: kiley sc. Cell Growth Differ. 1999 Apr;10(4):271-7. Cell Growth Differ. 1999. PMID: 10319997

6

Differential localization of protein kinase C isozymes in U937 cells: evidence for distinct isozyme functions during monocyte differentiation.

Kiley SC, Parker PJ. Kiley SC, et al. J Cell Sci. 1995 Mar;108 ( Pt 3):1003-16. doi: 10.1242/jcs.108.3.1003. J Cell Sci. 1995. PMID: 7622590

7

Hormone- and phorbol ester-activated protein kinase C isozymes mediate a reorganization of the actin cytoskeleton associated with prolactin secretion in GH4C1 cells.

Kiley SC, Parker PJ, Fabbro D, Jaken S. Kiley SC, et al. Mol Endocrinol. 1992 Jan;6(1):120-31. doi: 10.1210/mend.6.1.1738365. Mol Endocrinol. 1992. PMID: 1738365

8

12-Deoxyphorbol-13-O-phenylacetate-20-acetate is not protein kinase C-beta isozyme-selective in vivo.

Kiley SC, Olivier AR, Gordge PC, Ryves WJ, Evans FJ, Ways DK, Parker PJ. Kiley SC, et al. Carcinogenesis. 1994 Feb;15(2):319-24. doi: 10.1093/carcin/15.2.319. Carcinogenesis. 1994. PMID: 8313525

9

Protein kinase C heterogeneity in GH4C1 rat pituitary cells. Characterization of a Ca2(+)-independent phorbol ester receptor.

Kiley S, Schaap D, Parker P, Hsieh LL, Jaken S. Kiley S, et al. J Biol Chem. 1990 Sep 15;265(26):15704-12. J Biol Chem. 1990. PMID: 2394744 Free article.

10

Differential regulation of protein kinase C isozymes by thyrotropin-releasing hormone in GH4C1 cells.

Kiley SC, Parker PJ, Fabbro D, Jaken S. Kiley SC, et al. J Biol Chem. 1991 Dec 15;266(35):23761-8. J Biol Chem. 1991. PMID: 1748652 Free article.

We previously reported that thyrotropin-releasing hormone (TRH) selectively down-modulates epsilon-PKC with no effect on alpha- or beta-PKCs (Kiley, S.C., Schaap, D., Parker, P., Hsieh, L.-L., and Jaken, S. (1990) J. ...TRH stimulates three distinct DAG phase …

We previously reported that thyrotropin-releasing hormone (TRH) selectively down-modulates epsilon-PKC with no effect on alpha- or beta-PKCs …

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

62 results

Search Page